Interestingly, transgenic expression of CDH1 in melanoma blocks p38 signaling, suggesting that the loss of CDH1 leads to a more active p38 pathway indicating a direct crosstalk between p38 activity and CDH1 expression [45]. The gene discussed is CDH1; the disease is melanoma.